newsfilter
← Latest News
Business Wire·

Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration, today announced the appointment of Evert (Eef) Schimmelpennink to its Board of Directo